title: Risk behaviour and HTLV-1 seropositivity in injecting drug users.
authors.forename: G
authors.initials: G
authors.lastname: Rezza
authors.forename: A
authors.initials: A
authors.lastname: Lazzarin
authors.forename: C
authors.initials: C
authors.lastname: Uberti-Foppa
authors.forename: M
authors.initials: M
authors.lastname: Tumbarello
authors.forename: F
authors.initials: F
authors.lastname: Menniti-Ippolito
authors.forename: P
authors.initials: P
authors.lastname: Pezzotti
authors.forename: F
authors.initials: F
authors.lastname: Titti
authors.forename: P
authors.initials: P
authors.lastname: Verani
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D005260:Female; D015481:HTLV-I Antibodies / Q000032:analysis; D015490:HTLV-I Infections / Q000635:transmission*; D006801:Humans; D007558:Italy; D008297:Male; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications*; D013594:Syringes / Q000009:adverse effects*
chemical_list: D015481:HTLV-I Antibodies